TMCV.NS(TMCV.NS)
TMCV.NS
No analyst ratings available
No analyst price targets available for TMCV.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $884.33B | $962.18B | $1.07T |
| Low | $825.97B | $880.34B | $1.05T |
| High | $935.08B | $1.03T | $1.08T |
| EBITDA Avg | $111.49B | $121.30B | $134.39B |
| Low | $104.13B | $110.98B | $132.68B |
| High | $117.89B | $129.84B | $136.10B |
| EBIT Avg | $70.32B | $76.51B | $84.76B |
| Low | $65.67B | $70.00B | $83.68B |
| High | $74.35B | $81.89B | $85.84B |
| Net Income Avg | $67.07B | $81.58B | $90.37B |
| Low | $65.70B | $72.66B | $85.80B |
| High | $76.92B | $94.41B | $109.71B |
| EPS Avg | $18.86 | $22.30 | $25.42 |
| Low | $17.84 | $19.74 | $23.30 |
| High | $20.89 | $25.64 | $29.80 |
| Analysts (Rev / EPS) | 15 / 13 | 15 / 14 | 6 / 6 |